Safety and Efficacy of TCD-10023 (Ultimaster) Drug-eluting Stent in STEMI Patients - MASTER Study

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It plans to enroll 500 participants.

Also called NCT02828683

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 500 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT02828683
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Brazil, Italy, North Macedonia, Serbia, Spain (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02828683. Randomized; single masking; primary purpose treatment. Start 2013-07 (registry gives no type); primary completion 2016-07 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Safety and Efficacy of TCD-10023 (Ultimaster) Drug-eluting Stent in STEMI Patients - MASTER Study
Acronym
MASTER
Condition
Acute ST Segment Elevation Myocardial Infarction
Intervention (Device)
PCI (percutaneous coronary intervention) in patients with ST-elevation myocardial infarction
Intervention (Device)
PCI in patients with ST-elevation myocardial infarction
Lead sponsor
Terumo Europe N.V. (class: industry)

Record details

Record id
cardio:ct-nct02828683
Content hash
ce27f31f7c3f831d43509c3780dd717a098db5fd74bd39ec7b7c180daf2c11a5